CORC  > 浙江工商大学
Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model
Qiu, Yun-Qing[1]; Zhou, Jue[2]; Kang, Xin-Shan[3]; Ding, Lie-Ming[4]; Yu, Wei[1]; Tan, Fen-Lai[4]; Deng, Dan-Feng[1]
2014
卷号4
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5549967
专题浙江工商大学
作者单位1.[1]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
2.[2]Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou 310012, Zhejiang, Peoples R China
3.[3]Fujian Haixi Pharmaceut Co Ltd, Fuzhou 350002, Peoples R China
4.[4]Zhejiang Beta Pharma Co Ltd, Hangzhou 311100, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Qiu, Yun-Qing[1],Zhou, Jue[2],Kang, Xin-Shan[3],et al. Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model[J],2014,4.
APA Qiu, Yun-Qing[1].,Zhou, Jue[2].,Kang, Xin-Shan[3].,Ding, Lie-Ming[4].,Yu, Wei[1].,...&Deng, Dan-Feng[1].(2014).Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.,4.
MLA Qiu, Yun-Qing[1],et al."Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model".4(2014).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace